Canlyniadau Chwilio am Awdur

1

RNA Editing of the Human Serotonin 5-HT2C Receptor Alterations in Suicide and Implications for Serotonergic Pharmacotherapy gan Colleen M. Niswender

Cyhoeddwyd 2001

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
2

Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications gan Yin Shen, Colleen M. Niswender

Cyhoeddwyd 2014

Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
3

Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease gan Colleen M. Niswender, P. Jeffrey Conn

Cyhoeddwyd 2010

Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
4

Serotonin 5‐HT2C Receptor RNA Editing Alters Receptor Basal Activity gan Katharine Herrick‐Davis, Ellinor Grinde, Colleen M. Niswender

Cyhoeddwyd 1999

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
5

Novel pharmacological targets for GABAergic dysfunction in ADHD gan Anthony S. Ferranti, Deborah J. Luessen, Colleen M. Niswender

Cyhoeddwyd 2024

Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
6

Mglur4-Positive Allosteric Modulation as Potential Treatment for Parkinson’s Disease gan Corey R. Hopkins, Craig W. Lindsley, Colleen M. Niswender

Cyhoeddwyd 2009

Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
7

Glutamate Receptors as Therapeutic Targets for Parkinsons Disease gan Kari A. Johnson, P. Jeffrey Conn, Colleen M. Niswender

Cyhoeddwyd 2009

Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
8

Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders gan P. Jeffrey Conn, Craig W. Lindsley, Jens Meiler, Colleen M. Niswender

Cyhoeddwyd 2014

Cael y testun llawn Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
9

Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders gan Nicole M. Fisher, Mabel Seto, Craig W. Lindsley, Colleen M. Niswender

Cyhoeddwyd 2018

Cael y testun llawn Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
10

Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated gan Jennifer Ayala, Colleen M. Niswender, Qingwei Luo, Jessica L. Banko, P. Jeffrey Conn

Cyhoeddwyd 2007

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
11

RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity gan Colleen M. Niswender, Sara C. Copeland, Katharine Herrick‐Davis, Ronald B. Emeson, Elaine Sanders‐Bush

Cyhoeddwyd 1999

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
12

RNA‐editing of the 5‐HT2C receptor alters agonist‐receptor‐effector coupling specificity gan Kelly A. Berg, Jodie Cropper, Colleen M. Niswender, Elaine Sanders‐Bush, Ronald B. Emeson, William P. Clarke

Cyhoeddwyd 2001

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
13

Discovery of a Novel Chemical Class of mGlu5 Allosteric Ligands with Distinct Modes of Pharmacology gan Alexis S. Hammond, Alice L. Rodriguez, Steven D. Townsend, Colleen M. Niswender, Karen J. Gregory, Craig W. Lindsley, P. Jeffrey Conn

Cyhoeddwyd 2010

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
14

Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors gan Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, Thomas M. Bridges, Karen J. Gregory, Colleen M. Niswender, P. Jeffrey Conn

Cyhoeddwyd 2016

Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
15

Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M4 Muscarinic Receptor as a Novel Therapeutic Target gan Rocco G. Gogliotti, Nicole M. Fisher, Branden J. Stansley, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender

Cyhoeddwyd 2018

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
16

Selective Actions of Novel Allosteric Modulators Reveal Functional Heteromers of Metabotropic Glutamate Receptors in the CNS gan Yin Shen, Meredith J. Noetzel, Kari A. Johnson, Rocio Zamorano, Nidhi Jalan‐Sakrikar, Karen J. Gregory, P. Jeffrey Conn, Colleen M. Niswender

Cyhoeddwyd 2013

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
17

Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery gan Bruce J. Melancon, Corey R. Hopkins, Michael R. Wood, Kyle A. Emmitte, Colleen M. Niswender, Arthur Christopoulos, P. Jeffrey Conn, Craig W. Lindsley

Cyhoeddwyd 2011

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
18

Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction gan Adam G. Walker, Cody J. Wenthur, Zixiu Xiang, Jerri M. Rook, Kyle A. Emmitte, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn

Cyhoeddwyd 2015

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
19

A Novel Class of Succinimide-Derived Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Provides Insight into a Disconnect in Activity between the Rat and... gan Hyekyung P. Cho, Darren W. Engers, Daryl F. Venable, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn, Kyle A. Emmitte, Alice L. Rodriguez

Cyhoeddwyd 2014

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
20

Synthesis and Evaluation of a Series of Heterobiarylamides That Are Centrally Penetrant Metabotropic Glutamate Receptor 4 (mGluR4) Positive Allosteric Modulators (PAMs) gan Darren W. Engers, Colleen M. Niswender, C. David Weaver, Satyawan Jadhav, Usha N. Menon, Rocio Zamorano, P. Jeffrey Conn, Craig W. Lindsley, Corey R. Hopkins

Cyhoeddwyd 2009

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:

RNA Editing of the Human Serotonin 5-HT2C Receptor Alterations in Suicide and Implications for Serotonergic Pharmacotherapy gan Colleen M. Niswender

Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications gan Yin Shen, Colleen M. Niswender

Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease gan Colleen M. Niswender, P. Jeffrey Conn

Serotonin 5‐HT<sub>2C</sub> Receptor RNA Editing Alters Receptor Basal Activity gan Katharine Herrick‐Davis, Ellinor Grinde, Colleen M. Niswender

Novel pharmacological targets for GABAergic dysfunction in ADHD gan Anthony S. Ferranti, Deborah J. Luessen, Colleen M. Niswender

Mglur4-Positive Allosteric Modulation as Potential Treatment for Parkinson’s Disease gan Corey R. Hopkins, Craig W. Lindsley, Colleen M. Niswender

Glutamate Receptors as Therapeutic Targets for Parkinsons Disease gan Kari A. Johnson, P. Jeffrey Conn, Colleen M. Niswender

Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders gan P. Jeffrey Conn, Craig W. Lindsley, Jens Meiler, Colleen M. Niswender

Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders gan Nicole M. Fisher, Mabel Seto, Craig W. Lindsley, Colleen M. Niswender

Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated gan Jennifer Ayala, Colleen M. Niswender, Qingwei Luo, Jessica L. Banko, P. Jeffrey Conn

RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity gan Colleen M. Niswender, Sara C. Copeland, Katharine Herrick‐Davis, Ronald B. Emeson, Elaine Sanders‐Bush

RNA‐editing of the 5‐HT<sub>2C</sub> receptor alters agonist‐receptor‐effector coupling specificity gan Kelly A. Berg, Jodie Cropper, Colleen M. Niswender, Elaine Sanders‐Bush, Ronald B. Emeson, William P. Clarke

Discovery of a Novel Chemical Class of mGlu<sub>5</sub> Allosteric Ligands with Distinct Modes of Pharmacology gan Alexis S. Hammond, Alice L. Rodriguez, Steven D. Townsend, Colleen M. Niswender, Karen J. Gregory, Craig W. Lindsley, P. Jeffrey Conn

Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors gan Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, Thomas M. Bridges, Karen J. Gregory, Colleen M. Niswender, P. Jeffrey Conn

Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M<sub>4</sub> Muscarinic Receptor as a Novel Therapeutic Target gan Rocco G. Gogliotti, Nicole M. Fisher, Branden J. Stansley, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender

Selective Actions of Novel Allosteric Modulators Reveal Functional Heteromers of Metabotropic Glutamate Receptors in the CNS gan Yin Shen, Meredith J. Noetzel, Kari A. Johnson, Rocio Zamorano, Nidhi Jalan‐Sakrikar, Karen J. Gregory, P. Jeffrey Conn, Colleen M. Niswender

Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery gan Bruce J. Melancon, Corey R. Hopkins, Michael R. Wood, Kyle A. Emmitte, Colleen M. Niswender, Arthur Christopoulos, P. Jeffrey Conn, Craig W. Lindsley

Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction gan Adam G. Walker, Cody J. Wenthur, Zixiu Xiang, Jerri M. Rook, Kyle A. Emmitte, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn

Canlyniadau Chwilio - Colleen M. Niswender

RNA Editing of the Human Serotonin 5-HT2C Receptor Alterations in Suicide and Implications for Serotonergic Pharmacotherapy gan Colleen M. Niswender

Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications gan Yin Shen, Colleen M. Niswender

Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease gan Colleen M. Niswender, P. Jeffrey Conn

Serotonin 5‐HT<sub>2C</sub> Receptor RNA Editing Alters Receptor Basal Activity gan Katharine Herrick‐Davis, Ellinor Grinde, Colleen M. Niswender

Novel pharmacological targets for GABAergic dysfunction in ADHD gan Anthony S. Ferranti, Deborah J. Luessen, Colleen M. Niswender

Mglur4-Positive Allosteric Modulation as Potential Treatment for Parkinson’s Disease gan Corey R. Hopkins, Craig W. Lindsley, Colleen M. Niswender

Glutamate Receptors as Therapeutic Targets for Parkinsons Disease gan Kari A. Johnson, P. Jeffrey Conn, Colleen M. Niswender

Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders gan P. Jeffrey Conn, Craig W. Lindsley, Jens Meiler, Colleen M. Niswender

Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders gan Nicole M. Fisher, Mabel Seto, Craig W. Lindsley, Colleen M. Niswender

Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated gan Jennifer Ayala, Colleen M. Niswender, Qingwei Luo, Jessica L. Banko, P. Jeffrey Conn

RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity gan Colleen M. Niswender, Sara C. Copeland, Katharine Herrick‐Davis, Ronald B. Emeson, Elaine Sanders‐Bush

RNA‐editing of the 5‐HT<sub>2C</sub> receptor alters agonist‐receptor‐effector coupling specificity gan Kelly A. Berg, Jodie Cropper, Colleen M. Niswender, Elaine Sanders‐Bush, Ronald B. Emeson, William P. Clarke

Discovery of a Novel Chemical Class of mGlu<sub>5</sub> Allosteric Ligands with Distinct Modes of Pharmacology gan Alexis S. Hammond, Alice L. Rodriguez, Steven D. Townsend, Colleen M. Niswender, Karen J. Gregory, Craig W. Lindsley, P. Jeffrey Conn

Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors gan Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, Thomas M. Bridges, Karen J. Gregory, Colleen M. Niswender, P. Jeffrey Conn

Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M<sub>4</sub> Muscarinic Receptor as a Novel Therapeutic Target gan Rocco G. Gogliotti, Nicole M. Fisher, Branden J. Stansley, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender

Selective Actions of Novel Allosteric Modulators Reveal Functional Heteromers of Metabotropic Glutamate Receptors in the CNS gan Yin Shen, Meredith J. Noetzel, Kari A. Johnson, Rocio Zamorano, Nidhi Jalan‐Sakrikar, Karen J. Gregory, P. Jeffrey Conn, Colleen M. Niswender

Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery gan Bruce J. Melancon, Corey R. Hopkins, Michael R. Wood, Kyle A. Emmitte, Colleen M. Niswender, Arthur Christopoulos, P. Jeffrey Conn, Craig W. Lindsley

Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction gan Adam G. Walker, Cody J. Wenthur, Zixiu Xiang, Jerri M. Rook, Kyle A. Emmitte, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn

Offerynnau Chwilio:

Pynciau Perthynol